Can the controversy of the role of aluminum in Alzheimer's disease be resolved? What are the suggested approaches to this controversy and methodological issues to be considered?

Journal of Toxicology and Environmental Health - Part A

Volumn 48, Issue 6, 1996, Pages 615-635

  Savory, John ^a,h   Exley, Christopher ^b   Forbes, William F ^c   Huang, Yue ^a   Joshi, Jayant G ^d   Kruck, Theo ^e   McLachlan, Donald R C ^f   Wakayama, Ikuro ^g  

^a UNIVERSITY OF VIRGINIA   (United States)

^b KEELE UNIVERSITY   (United Kingdom)

^c UNIVERSITY OF WATERLOO   (Canada)

^d UNIVERSITY OF TENNESSEE   (United States)

^e UNIVERSITY OF TORONTO   (Canada)

^f UNIVERSITY OF TORONTO   (Canada)

^g Kansai College of Oriental Medicine   (Japan)

^h UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALUMINUM; AMYLOID BETA PROTEIN; DEFEROXAMINE; DRINKING WATER;

ALZHEIMER DISEASE; CONFERENCE PAPER; DRUG EFFICACY; HEMODIALYSIS; HUMAN; KIDNEY FAILURE; METHODOLOGY; NERVE DEGENERATION; NEUROPATHOLOGY; NEUROTOXICITY; NONHUMAN; OCCUPATIONAL EXPOSURE; PATHOGENESIS; PRIORITY JOURNAL; RABBIT;

ALUMINUM; ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN PRECURSOR; ANIMALS; DEFEROXAMINE; ENVIRONMENTAL EXPOSURE; HUMANS; NERVE DEGENERATION; NEUROFIBRILS; RENAL DIALYSIS; RESEARCH DESIGN; RISK FACTORS;

ANIMALIA; ORYCTOLAGUS CUNICULUS;

EID: 0029793482     PISSN: 15287394     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (88)

1. Abdel-Ghany, M., El-Sebae, A. K., and Shalloway, D. 1993. Aluminium-induced nonenzymatic phospho-incorporation in to human tau and other proteins. J. Biol. Chem. 268:11976-11981.
2. Ackrill, P., and Day, J. P. 1993. The use of desferrioxamine in dialysis-associated aluminium disease. Moving Points Nephrol. 102:125-134.
3. Arispe, N., Rojas, E., and Pollard, H. B. 1993. Alzheimer disease amyloid β protein forms calcium channels in bilayer membranes: Blockade by tromethamine and aluminum. Proc. Natl. Acad. Sci. USA 90:567-571.
4. Bertholf, R. L., Herman, M. M., Savory, J., Carpenter, R. M., Sturgill, B. C., Katsetos, C. D., Vandenberg, S. R., and Wills, M. R. 1989. A long-term intravenous model of aluminum maltol toxicity in rabbits: Tissue distribution, hepatic, renal, and neuronal cytoskeletal changes associated with systemic exposure. Toxicol. Appl. Pharmacol. 98:58-74.
5. Birchall, J. D., Exley, C., Chappell, J. S., and Phillips, M. J. 1989. Acute toxicity of aluminum to fish eliminated in silicon-rich acid waters. Nature 338:146-148.
6. Brun, A., and Dictor, M. 1981. Senile plaques and tangles in dialysis dementia. Acta Pathol. Microbiol. Scand. A 89:193-198.
7. Candy, J. M., Oakley, A. E., Klinowski, J., Carpenter, T. A., Perry, R. H., Atack, J. R., Perry, E. K., Blessed, G., Fairbairn, A., and Edwardson, J. A. 1986. Aluminosilicates and senile plaque formation in Alzheimer's disease. Lancet 1:354-357.
8. Candy, J. M., McArthur, F. K., Oakley, A. E., Taylor, G. A., Chen, C. P. L.-H., Mountfort, S. A., Thompson, J. E., Chalker, P. R., Bishop, H. E., Beyreuther, K., Perry, G., Ward, M. K., Martyn, C. N., and Edwardson, J. A. 1992. Aluminium accumulation in relation to senile plaque and neurofibrillary tangle formation in the brains of patients with renal failure. J. Neurol. Sci. 107:210-218.
9. Chafi, A. H., Hauw, J.-J., Rancurel, G., Berry, J.-P., and Galle, C. 1991. Absence of aluminium in Alzheimer's disease brain tissue: Electron microprobe and ion microprobe studies. Neurosci. Lett. 123:61-64.
10. Chong, Y.-H., and Suh, Y.-H. 1995. Aggregation of amyloidprecursor protein by aluminium in vitro. Brain Res. 670:137-141.
11. Clauberg, M., and Joshi, J. G. 1993. Regulation of serine protease activity by aluminum: Implications for Alzheimer disease. Proc. Natl. Acad. Sci. USA 90:1009-1012.
12. Crapper, D. R., Krishnan, S. S., and Dalton, A. J. 1973. Brain aluminum distribution in Alzheimer's disease and experimental neurofibrillary degeneration. Science 180:511-513.
13. Crowther, R. A., Olesen, O. F., Smith, M. J., Jakes, R., and Goedert, M. 1994. Assembly of Alzheimer-like filaments from full-length tau protein. FEBS Lett. 337:135-138.
14. Dahl, D., and Bignami, A. 1978. Immunochemical cross-reactivity of normal neurofibrils and aluminum-induced neurofibrillary tangles. Immunofluorescence study with antineurofilament serum. Exp. Neurol. 58:74-80.
15. Dyrks, T., Dyrks, E., Hartmann, T., Masters, C., and Beyreuther, K. 1992. Amyloidogenicity of βA4 and βA4-bearing amyloid protein precursor fragments by metal-catalyzed oxidation. J. Biol. Chem. 267:18210-18217.
16. Edwardson, J. A., Moore, P. B., Ferrier, I. N., Lilley, J. S., Newton, G. W. A., Barker, J., Templar, J., and Day, J. P. 1993. Effect of silicon on gastrointestinal absorption of aluminium. Lancet 342:211-212.
17. El-Sales, M. A. 1993. Aluminium interaction with human brain tau protein phosphorylation by various kinases. J. Environ. Sci. Health B 28:763-77.
18. Exley, C., Price, N. C., Kelly, S. M., and Birchall, J. D. 1993. An interaction of β-amyloid with aluminium in vitro. FEBS Lett. 324:293-295.
19. Exley, C., Schley, L., Murray, S., Hackney, C. M., and Birchall, J. D. 1995. Aluminium, β-amyloid and non-enzymatic glycosylation. FEBS Lett. 364:182-184.
20. Exley, C., Burgess, E., Day, J. P., Jeffery, E. H., Melethil, S., and Yokel, R. A. 1996. Aluminum toxicokinetics. J. Toxicol. Environ. Health 48:569-584.
21. Fasman, G. D., Perczel, A., and Moore, C. D. 1995. Solubilization of β-amyloid-(1-42)-peptide: Reversing the β-sheet conformation induced by aluminum with silicates. Proc. Natl. Acad. Sci. USA 92:369-371.
22. Flaten, T. P. 1990. Geographical associations between aluminium in drinking water and death rates with dementia (including Alzheimer's disease), Parkinson's disease and amyotrophic lateral sclerosis in Norway. Environ. Geochem. Health 12:152-167.
23. Flaten, T. P., Alfrey, A. C., Birchall, J. D., Savory, J., and Yokel, R. A. 1996. Status and future concerns of clinical and environmental aluminum toxicity. J. Toxicol. Environ. Health 48:527-541.
24. Forbes, W. F., and McAiney, C. A. 1992. Aluminium and dementia. Lancet 340:668-669.
25. Forbes, W. F., Hayward, L. M., and Agwani, N. 1991. Dementia, aluminium and fluoride. Lancet 338:1592-1593.
26. Forbes, W. F., Hayward, L. M., and Agwani, N. 1992. Geochemical risk factors for mental functioning, based on the Ontario Longitudinal Study of Aging (LSA). I. Results from a preliminary investigation. Can. J. Aging 11(3):269-280.
27. Forbes, W. F., McAiney, C. A., Hayward, L. M., and Agwani, N. 1994. Geochemical risk factors for mental functioning, based on the Ontario Longitudinal Study of Aging (LSA) II. The role of pH. Can. J. Aging 13(2):231-238.
28. Forbes, W. F., Gentleman, J. F., and Maxwell, C.J. 1995a. Concerning the role of aluminum in causing dementia. Exp. Gerontol. 30:23-32.
29. Forbes, W. F., Lessard, S., and Gentleman, J. F. 1995b. Geochemical risk factors for mental functioning, based on the Ontario Longitudinal Study of Aging (LSA). V. Comparisons of the results, relevant to aluminum water concentrations, obtained frthe LSA and from death certificates mentioning dementia. Can. J. Aging 14(4):642-656.
30. Garruto, R. M., Fukatsu, R., Yanagihara, R., Gajdusek, D. C., Hook, G., and Fiori, C. E. 1984. Imaging of calcium and aluminum in neurofibrillary tangle-bearing neurons in parkinsonism-dementia of Guam. Proc. Natl. Acad. Sci. USA 81:1875-1879.
31. Garruto, R. M., Swyt, C., Fiori, C. E., Yanagihara, R., and Gajdusek, D. C. 1985. Intraneuronal deposition of calcium and aluminium in amyotrophic lateral sclerosis of Guam. Lancet 2:1353.
32. Garruto, R. M., Swyt, C., Yanagihara, R., Fiori, C. E., and Gajdusek, D. C. 1986. Intraneuronal co-localization of silicon with calcium and aluminum in amyotrophic lateral sclerosis and parkinsonism with dementia of Guam. N. Engl. J. Med. 315:711-712.
33. Good, P. F., and Perl, D. P. 1993. Laser microprobe mass analysis in Alzheimer's disease. Ann. Neurol. 34:413.
34. Good, P. F., Perl, D. P., Bierer, L. M., and Schmeidler, J. 1992. Selective accumulation of aluminum and iron in the neurofibrillary tangles of Alzheimer's disease: A laser microprobe (LAMMA) study. Ann. Neurol. 31:286-292.
35. Harrington, C. R., Wischik, C. M., McArthur, F. K., Taylor, G. A., Edwardson, J. A., and Candy, J. M. 1994. Alzheimer's-disease-like changes in tau protein processing: Association with aluminium accumulation in brains of renal dialysis patients. Lancet 343:993-997.
36. Huang, Y., Savory, J., Herman, M. M., Nicholson, J. R., Reyes, M. R., Boyd, J. C., and Wills, M. R. 1995. Quantative evaluation of Al maltolate-induced neurodegeneration with subsequent Al removal by desferrioxamine treatment. Neurotoxicology 16:291-296.
37. Jacobs, R. W., Duong, T., Jones, R. E., Trapp, G. A., and Scheibel, A. B. 1989. A reexamination of aluminum in Alzheimer's disease: Analysis by energy dispersive x-ray microprobe and flameless atomic absorption spectrophotometry. Can. J. Neurol. Sci. 16:498-503.
38. Katsetos, C. D., Savory, J., Herman, M. M., Carpenter, R. M., Frankfurter, A., Hewitt, C. D., and Wills, M. R. 1990. Neuronal cytoskeletal lesions induced in the CNS by intraventricular and intravenous aluminium maltol in rabbits. Neuropathol. Appl. Neurobiol. 16:511-528.
39. Kawahara, M., Muramoto, K., Kobayashi, K., Mori, H., and Kuroda, Y. 1994. Aluminum promotes the aggregation of Alzheimer's amyloid β-protein in vitro. Biochem. Biophys. Res. Commun. 198:531-535.
40. Klatzo, I., Wisniewski, H., and Streicher, E. 1965. Experimental production of neurofibrillary degeneration. I. Light microscopic observations. J. Neuropathol. Exp. Neurol. 24:187-199.
41. Kruck, T. P. A., and Crapper McLachlan, D. R. 1989. Aluminum as a pathogenic factor in senile dementia of the Alzheimer type: Ion specific chelation. In Alzheimer's disease and related disorders, eds. K. Iqbal, H. W. Wisniewski, and B. Winblad, pp. 1155-1167. New York: Alan R. Liss.
42. Kuroda, Y., and Kawahara, M. 1994. Aggregation of amyloid β-protein and its neurotoxicity: Enhancement by aluminum and other metals. Tohoku J. Exp. Med. 174:263-268.
43. Landsberg, J. P., McDonald, B., and Watt, F. 1992. Absence of aluminium in neuritic plaque cores in Alzheimer's disease. Nature 360:65-68.
44. Landsberg, J. P., McDonald, B., Grime, G., and Watt, F. 1993. Microanalysis of senile plaques using nuclear microscopy. J. Geriatr. Psychiatry Neurol. 6:97-104.
45. Lovell, M. A., Ehmann, W. D., and Markesbery, W. R. 1993a. Laser microprobe analysis of brain aluminum in Alzheimer's disease. Ann. Neurol. 33:36-42.
46. Lovell, M. A., Ehmann, W. D., and Markesbery, W. R. 1993b. Laser microprobe mass analysis in Alzheimer's disease; Reply. Ann. Neurol. 34:413-415.
47. Lovell, M. A., Ehmann, W. D., Markesbery, W. R., Melethil, S., Swyt, C. R., and Zatta, P. F. 1996. Aluminum biological standards: What are the needs? J. Toxicol. Environ. Health 48:637-648.
48. Mantyh, P. W., Ghilardi, J. R., Rogers, S., DeMaster, E., Allen, C. J., Stimson, E. R., and Maggio, J. E. 1993. Aluminum, iron and zinc ions promote aggregation of physiological concentrations of β-amyloid peptide. J. Neurochem. 61:1171-1174.
49. Markesbery, W. R., Ehmann, W. D., Hossain, T. I. M., Alauddin, M., and Goodin, D. T. 1981. Instrumental neutron activation analysis of brain aluminum in Alzheimer's disease and aging. Ann. Neurol. 10:511-516.
50. Markesbery, W. R., Lovell, M. A., and Ehmann, W. D. 1993. Laser microprobe analysis of trace elements in senile plaques in Alzheimer's disease. J. Neuropathol. Exp. Neurol. 52:301.
51. Martin, R. B. 1994. Aluminum: A neurotoxic product of acid rain. Acct. Chem. Res. 27:204-210.
52. Martyn, C. N., Barker, D. J. P., Osmond, C., Harris, E. C., Edwardson, J. A., and Lacey, R. F. 1989. Geographical relation between Alzheimer's disease and aluminium in drinking water. Lancet i:59-62.
53. Matsuo, E. S., Shin, R.-S., Billingsley, M. L., Van deVoorde, A., O'Connor, M., Trojanowski, J. Q., and Lee, V. M.-L. 1994. Biopsy-derived adult human brain tau is phosphorylated at many of the same sites as Alzheimer's disease paired helical filament tau. Neuron 13:989-1002.
54. Mattson, M. P., Lovell, M. A., Ehmann, W. D., and Markesbery, W. R. 1993. Comparison of the effects of elevated intracellular aluminum and calcium levels on neuronal survival and tau immunoreactivity. Brain Res. 602:21-31.
55. McDermott, J. R., Smith, A. I., Iqbal, K., and Wisniewski, H. M. 1977. Aluminium and Alzheimer's disease. Lancet ii:710-711.
56. McLachlan, D. R. C. 1995. Aluminum and the risk for Alzheimer's disease. Environmetrics 6:233-275.
57. McLachlan, D. R. C., Dalton, A. J., Kruck, T. P. A., Bell, M. Y., Smith, W. L., Kalow, W., and Andrews, D. F. 1991a. Intramuscular desferrioxamine in patients with Alzheimer's disease. Lancet 337:1304-1308.
58. McLachlan, D. R. C., Kruck, T. P., Lukiw, W. J., and Krishnan, S. S. 1991b. Would decreased aluminum ingestion reduce the incidence of Alzheimer's disease? Can. Med. Assoc. J. 145:793-804.
59. McLachlan, D. R. C., Smith, W. L., and Kruck, T. P. 1993. Desferrioxamine and Alzheimer's disease: Video home behavior assessment of clinical course and measures of brain aluminum. Ther. Drug. Monit. 15:602-607.
60. McLachlan, D. R. C., Bergeron, C., Smith, J. E., Boomer, D., and Rifat, S. L. 1996. Risk for neuropathologically confirmed Alzheimer's disease and residual aluminum in municipal drinking water employing weighted residential histories. Neurology 46:401-405.
61. Neri, L. C., and Hewitt, D. 1991. Aluminium, Alzheimer's disease, and drinking water. Lancet 338:390.
62. Perl, D. P., and Brody, A. R. 1980. Alzheimer's disease: X-ray spectrometric evidence of aluminum accumulation in neurofibrillary tangle-bearing neurons. Science 208:297-299.
63. Perl, D. P., Gajdusek, D. C., Garruto, R. M., Yanagihara, R. T., and Gibbs, C. J., Jr. 1982. Intraneuronal aluminum accumulation in amyotrophic lateral sclerosis and parkinsonism-dementia of Guam. Science 217:1053-1055.
64. Perl, D. P., Munoz-Garcia, D., and Good, P. L. 1986. Laser microprobe mass analyzer (LAMMA) - A new approach to the study of the association of aluminum and neurofibrillary tangle formation. In Alzheimer's and Parkinson's diseases, eds. A. Fisher and I. Hanin, pp. 241-248. New York: Plenum.
65. Perl, D. P., Good, P. F., and Hof, P. R. 1990. Unpublished results presented at the 2nd International Conference on Aluminum in Health, Orlando, FL, December.
66. Rifat, S. L., Eastwood, M. R., McLachlan, D. R. C., and Corey, P. N. 1990. Effect of exposure of miners to aluminium powder. Lancet 336:1162-1165.
67. Savory, J., Herman, M. M., Erasmus, R. T., Boyd, J. C., and Wills, M. R. 1994. Partial reversal of aluminium-induced neurofibrillary degeneration by desferrioxamine in adult male rabbits. Neuropathol. Appl. Neurobiol. 20:31-37.
68. Savory, J., Huang, Y., Herman, M. M., Reyes, M. R., and Wills, M. R. 1995a. Tau immunoreactivity associated with aluminum maltolate-induced neurofibrillary degeneration in rabbits. Brain Res. 669:325-329.
69. Savory, J., Huang, Y., Herman, M. M., Reyes, M. R., Boyd, J. C., and Wills, M. R. 1995b. Abnormal accumulation and partial reversal by desferrioxamine, in aluminum-induced neurofibrillary degeneration in rabbits. In Research advances in Alzheimer's disease and related disorders, eds. K. Iqbal, J. A. Mortimer, B. Winblad, and H. W. Wisniewski, pp. 543-551. New York: Wiley & Sons.
70. Savory, J., Huang, Y., Herman, M. M., and Wills, M. R. 1996. Quantitative image analysis of temporal changes in tau and neurofilament proteins during the course of acute experimental neurofibrillary degeneration; non-phosphorylated epitopes precede phosphorylation. Brain Res. 707:272-281.
71. Scholtz, C. L., Swash, M., Gray, A., Kogeorgos, J., and Marsh, F. 1987. Neurofibrillary neuronal degeneration in dialysis dementia: a feature of aluminum toxicity. Clin. Neuropathol. 6:93-97.
72. Schupf, N. 1992. Aluminum in drinking water and Alzheimer's disease: Methodological problems. Proc. Second Int. Conf. Aluminum and Health, Tampa, FL, pp. 53-59.
73. Scott, C. W., Fieles, A., Sygowski, L. A., and Caputo, C. B. 1993. Aggregation of tau protein by aluminum. Brain Res. 628:77-84.
74. Strong, M. J., Wolff, A. V., Wakayama, I., and Garruto, R. M. 1991. Aluminum-induced chronic myelopathy in rabbits. Neurotoxicology 12:9-22.
75. Terry, R. D., and Pena, C. 1965. Experimental production of neurofibrillary degeneration. 2. Electron microscopy, phosphatase histochemistry and electron probe analysis. J. Neuropathol. Exp. Neurol. 24:200-210.
76. Trapp, G. A., Miner, G. D., Zimmerman, R. L., Mastri, A. R., and Heston, L. L. 1978. Aluminum levels in brain in Alzheimer's disease. Biol. Psychiatry 13:709-718.
77. Traub, R. D., Rains, T. C., Garruto, R. M., Gajdusek, D. C., and Gibbs, C. J., Jr. 1981. Brain destruction alone does not elevate brain aluminum. Neurology 31:986-900.
78. Trojanowski, J. Q., Schmidt, M. L., Otvros, L., Hill, W. D., and Lee, V. M. Y. 1990. Vulnerability of the neuronal cytoskeleton in aging and Alzheimer's disease: Widespread involvement of all three major filament systems. Annu. Rev. Gerontol. Geriatrics 10:167-182.
79. Vyas, S. B., and Duffy, L. K. 1995. Stabilization of secondary structure of Alzheimer β-amyloid by aluminum(III) ions and D-Asp substitutions. Biochem. Biophys. Res. Commun. 206:718-723.
80. Walton, J., Tuniz, C., Fink, D., Jacobson, G., and Wilcox, D. 1995. Uptake of trace amounts of aluminum into the brain from drinking water. NeuroToxicology 16:187-190.
81. Ward, N. I., and Mason, J. A. 1987. Neutron activation analysis techniques for identifying elemental status in Alzheimer's disease. J. Radioanal. Nucl. Chem. Art. 113:515-526.
82. Wettstein, A., Aeppli, J., Gautschi, K., and Peters, M. 1991. Failure to find a relationship between mnestic skills of octogenarians and aluminum in drinking water. Int. Arch. Occup. Environ. Health 63:97-103.
83. Wills, R. R., and Savory, J. 1983. Aluminium poisoning: Dialysis encephalopathy, osteomalacia and anaemia. Lancet ii:29-34.
84. Wills, M. R., Hewitt, C. D., Savory, J., and Herman, M. M. 1993. Long-term oral aluminum administration in rabbits. II. Brain and other organs. Ann. Clin. Lab. Sci. 23:17-23.
85. Wisniewski, H. M., and Wen, G. Y. 1992. Aluminium and Alzheimer's disease. In Aluminium in biology and medicine, pp. 142-164. Chichester: Ciba Foundation Symposium 169.
86. Wood, D. J., Cooper, C., Stevens, J., and Edwardson, J. 1988. Bone mass and dementia in hip fracture patients from areas with different aluminium concentrations in water supplies. Age Ageing 17:415-419.
87. Xu, N., Majidi, V., Markesbery, W. R., and Ehmann, W. D. 1992. Brain aluminum in Alzheimer's disease using an improved GFAAS method. NeuroToxicology 13:735-743.
88. Yoshimasu, F., Yasui, M., Yase, Y., Iwata, S., Gajdusek, D. C., Gibbs, C. J., and Chem, K. M. 1980. Studies on amyotrophic lateral sclerosis by neutron activation analysis-2. Comparative study of analytical results on Guam PD, Japanese ALS and Alzheimer's disease cases. Folia Psychiatr. Neurol. Jpn. 34:75-82.